Starting from a non-selective pyrazolo-pyrimidone lead, the sequential use of parallel medicinal chemistry and directed synthesis led to the discovery of potent, highly selective, and orally bioavailable PDE9 inhibitors. The availability of these tools allowed for a thorough evaluation of the therapeutic potential of PDE9 inhibition.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2009.03.024 | DOI Listing |
Publication Analysis
Top Keywords
discovery potent
8
selective orally
8
orally bioavailable
8
bioavailable pde9
8
pde9 inhibitors
8
potent selective
4
inhibitors potential
4
potential hypoglycemic
4
hypoglycemic agents
4
agents starting
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!